AI
Sunday, November 13, 2005 9:32:35 AM
PTIE
My second look at PTIE
I have just had a second look at PTIE. First I felt like PTIE sold the house because I felt remoxy was the best in their pipeline. I feel rest of the pipeline is no great shakes.PTIE has a market cap of around 350M $, getting 250M $ for the remoxy deal is really cool.
On the other hand many analysts are wildly guessing remoxy will go through FDA comfotably and win 90% of 2 Bil$ market(I have quoted it in my last post). I think it will get through FDA but getting a 90% slice of 2 Bil$ is like achieving the impossible. Because one of the adv with remoxy,analysts think is people can't abuse it with mixing with alcohol, doctors will prescribe it more. But the bottomline is doctors don't think their patients abuse the medication which they prescribe. They are confident about their patients and that's why they prescribe. So I feel it might be hitting a 500M$ per year target. That's why getting a 250M$ and 20% royalty for a 350M$ cap and 500M$ sales(guess) is a great deal. Now you can see why King shares went down after the deal.
Dr.Praveen
PS: Hi Alohadan, I will post a reply soon reg VRTX. Right now I am scratching my head over kerx
My second look at PTIE
I have just had a second look at PTIE. First I felt like PTIE sold the house because I felt remoxy was the best in their pipeline. I feel rest of the pipeline is no great shakes.PTIE has a market cap of around 350M $, getting 250M $ for the remoxy deal is really cool.
On the other hand many analysts are wildly guessing remoxy will go through FDA comfotably and win 90% of 2 Bil$ market(I have quoted it in my last post). I think it will get through FDA but getting a 90% slice of 2 Bil$ is like achieving the impossible. Because one of the adv with remoxy,analysts think is people can't abuse it with mixing with alcohol, doctors will prescribe it more. But the bottomline is doctors don't think their patients abuse the medication which they prescribe. They are confident about their patients and that's why they prescribe. So I feel it might be hitting a 500M$ per year target. That's why getting a 250M$ and 20% royalty for a 350M$ cap and 500M$ sales(guess) is a great deal. Now you can see why King shares went down after the deal.
Dr.Praveen
PS: Hi Alohadan, I will post a reply soon reg VRTX. Right now I am scratching my head over kerx
The power of imagination makes us Infinite
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
